Follow up note

DIAGNOSIS Emily, a 58-year-old female, was diagnosed with stage II breast cancer in March 2024. She has been undergoing chemotherapy and radiation therapy as part of her treatment plan. Her previous notes indicate a positive response to the treatment, with a reduction in tumor size noted in the last imaging study. Emily visited today to discuss ongoing symptoms and treatment progress. She reported experiencing fatigue and mild nausea, which have been persistent since the last chemotherapy session. Emily also mentioned occasional headaches and a decrease in appetite. PHYSICAL EXAMINATION Vital signs recorded today show a blood pressure of 120/80 mmHg, heart rate of 78 bpm, and temperature of 36.8°C. Emily appears slightly pale but is otherwise in good general condition. Recent blood tests indicate a slight decrease in white blood cell count, which is being monitored closely. Imaging studies from last week show further reduction in tumor size, consistent with the expected response to treatment. The clinical assessment suggests that Emily is responding well to the current treatment regimen, with no new concerning symptoms. The differential diagnosis includes chemotherapy-induced fatigue and nausea. The treatment plan will continue with the current chemotherapy protocol, with adjustments to anti-nausea medication to better manage symptoms. Emily is scheduled for a follow-up appointment in two weeks to reassess her condition and review blood test results. A referral to a nutritionist has been made to address Emily's decreased appetite and ensure adequate nutritional intake during treatment. November 1, 2024